Literature DB >> 25447236

Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.

S T Masoud1, L M Vecchio2, Y Bergeron3, M M Hossain4, L T Nguyen5, M K Bermejo6, B Kile7, T D Sotnikova8, W B Siesser9, R R Gainetdinov10, R M Wightman11, M G Caron12, J R Richardson13, G W Miller14, A J Ramsey15, M Cyr16, A Salahpour17.   

Abstract

The dopamine transporter is a key protein responsible for regulating dopamine homeostasis. Its function is to transport dopamine from the extracellular space into the presynaptic neuron. Studies have suggested that accumulation of dopamine in the cytosol can trigger oxidative stress and neurotoxicity. Previously, ectopic expression of the dopamine transporter was shown to cause damage in non-dopaminergic neurons due to their inability to handle cytosolic dopamine. However, it is unknown whether increasing dopamine transporter activity will be detrimental to dopamine neurons that are inherently capable of storing and degrading dopamine. To address this issue, we characterized transgenic mice that over-express the dopamine transporter selectively in dopamine neurons. We report that dopamine transporter over-expressing (DAT-tg) mice display spontaneous loss of midbrain dopamine neurons that is accompanied by increases in oxidative stress markers, 5-S-cysteinyl-dopamine and 5-S-cysteinyl-DOPAC. In addition, metabolite-to-dopamine ratios are increased and VMAT2 protein expression is decreased in the striatum of these animals. Furthermore, DAT-tg mice also show fine motor deficits on challenging beam traversal that are reversed with l-DOPA treatment. Collectively, our findings demonstrate that even in neurons that routinely handle dopamine, increased uptake of this neurotransmitter through the dopamine transporter results in oxidative damage, neuronal loss and l-DOPA reversible motor deficits. In addition, DAT over-expressing animals are highly sensitive to MPTP-induced neurotoxicity. The effects of increased dopamine uptake in these transgenic mice could shed light on the unique vulnerability of dopamine neurons in Parkinson's disease.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytosolic dopamine; Dopamine neuron loss; Dopamine transporter; MPTP; Motor deficits; Oxidative stress; Parkinson's disease; Transgenic mice; l-DOPA

Mesh:

Substances:

Year:  2014        PMID: 25447236      PMCID: PMC4505366          DOI: 10.1016/j.nbd.2014.10.016

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  70 in total

1.  A new motor test sensitive to aging and dopaminergic function.

Authors:  R Drucker-Colín; F García-Hernández
Journal:  J Neurosci Methods       Date:  1991-09       Impact factor: 2.390

2.  Optimizing the Temporal Resolution of Fast-Scan Cyclic Voltammetry.

Authors:  Brian M Kile; Paul L Walsh; Zoé A McElligott; Elizabeth S Bucher; Thomas S Guillot; Ali Salahpour; Marc G Caron; R Mark Wightman
Journal:  ACS Chem Neurosci       Date:  2012-01-30       Impact factor: 4.418

3.  Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

Authors:  T G Hastings; D A Lewis; M J Zigmond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

4.  Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.

Authors:  D A Di Monte; L E DeLanney; I Irwin; J E Royland; P Chan; M W Jakowec; J W Langston
Journal:  Brain Res       Date:  1996-10-28       Impact factor: 3.252

5.  Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  K Chiba; L A Peterson; K P Castagnoli; A J Trevor; N Castagnoli
Journal:  Drug Metab Dispos       Date:  1985 May-Jun       Impact factor: 3.922

6.  Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.

Authors:  J P Spencer; P Jenner; S E Daniel; A J Lees; D C Marsden; B Halliwell
Journal:  J Neurochem       Date:  1998-11       Impact factor: 5.372

Review 7.  The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.

Authors:  S Fahn; G Cohen
Journal:  Ann Neurol       Date:  1992-12       Impact factor: 10.422

8.  A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment.

Authors:  B Fornstedt; A Carlsson
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

9.  Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.

Authors:  Suzana Gispert; Filomena Ricciardi; Alexander Kurz; Mekhman Azizov; Hans-Hermann Hoepken; Dorothea Becker; Wolfgang Voos; Kristina Leuner; Walter E Müller; Alexei P Kudin; Wolfram S Kunz; Annabelle Zimmermann; Jochen Roeper; Dirk Wenzel; Marina Jendrach; Moisés García-Arencíbia; Javier Fernández-Ruiz; Leslie Huber; Hermann Rohrer; Miguel Barrera; Andreas S Reichert; Udo Rüb; Amy Chen; Robert L Nussbaum; Georg Auburger
Journal:  PLoS One       Date:  2009-06-03       Impact factor: 3.240

10.  Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression.

Authors:  Erin S Calipari; Mark J Ferris; Ali Salahpour; Marc G Caron; Sara R Jones
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  48 in total

1.  Palmitoylation by Multiple DHHC Enzymes Enhances Dopamine Transporter Function and Stability.

Authors:  Danielle E Bolland; Amy E Moritz; Daniel J Stanislowski; Roxanne A Vaughan; James D Foster
Journal:  ACS Chem Neurosci       Date:  2019-04-19       Impact factor: 4.418

Review 2.  The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration.

Authors:  Danielle E Mor; Malcolm J Daniels; Harry Ischiropoulos
Journal:  Mov Disord       Date:  2019-01-11       Impact factor: 10.338

3.  Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.

Authors:  Zili Luo; Katelin E Ahlers-Dannen; Mackenzie M Spicer; Jianqi Yang; Stephanie Alberico; Hanna E Stevens; Nandakumar S Narayanan; Rory A Fisher
Journal:  JCI Insight       Date:  2019-05-23

4.  Striatal magnetic resonance spectroscopy abnormalities in young adult SAPAP3 knockout mice.

Authors:  Dionyssios Mintzopoulos; Timothy E Gillis; Holly R Robertson; Triana Dalia; Guoping Feng; Scott L Rauch; Marc J Kaufman
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-01-01

5.  Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat/maneb toxicity in mice.

Authors:  Franziska Richter; Lauryn Gabby; Kimberly A McDowell; Caitlyn K Mulligan; Krystal De La Rosa; Pedrom C Sioshansi; Farzad Mortazavi; Ingrid Cely; Larry C Ackerson; Linda Tsan; Niall P Murphy; Nigel T Maidment; Marie-Françoise Chesselet
Journal:  Neurobiol Aging       Date:  2016-12-01       Impact factor: 4.673

Review 6.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

7.  LOWER POSTERIOR CINGULATE CORTEX GLUTATHIONE LEVELS IN OBSESSIVE-COMPULSIVE DISORDER.

Authors:  Brian P Brennan; J Eric Jensen; Christine Perriello; Harrison G Pope; Michael A Jenike; James I Hudson; Scott L Rauch; Marc J Kaufman
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-02-01

8.  Antioxidant-Mediated Modulation of Protein Reactivity for 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite.

Authors:  David G Anderson; Virginia R Florang; Josephine H Schamp; Garry R Buettner; Jonathan A Doorn
Journal:  Chem Res Toxicol       Date:  2016-06-15       Impact factor: 3.739

9.  Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals.

Authors:  Kelly M Lohr; Merry Chen; Carlie A Hoffman; Miranda J McDaniel; Kristen A Stout; Amy R Dunn; Minzheng Wang; Alison I Bernstein; Gary W Miller
Journal:  Toxicol Sci       Date:  2016-06-10       Impact factor: 4.849

10.  Selective and Mechanically Robust Sensors for Electrochemical Measurements of Real-Time Hydrogen Peroxide Dynamics in Vivo.

Authors:  Leslie R Wilson; Sambit Panda; Andreas C Schmidt; Leslie A Sombers
Journal:  Anal Chem       Date:  2017-12-15       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.